Background: Patient-reported outcomes (PROs) are outcomes evaluated by patients based on their perception of their disease and treatment.
Objectives: Determine antipsoriatic treatment-related adherence, quality of life (QoL) and satisfaction.
Materials And Methods: We conducted an observational cross-sectional, prospective, and single-center study in which PROs surveys were conducted on adherence (Morisky-Green [MG] test), treatment satisfaction (Spanish Questionnaire of Treatment Satisfaction in Psoriasis [CESTEP]) and QoL (Skindex-29 and DLQI).
Background: Patient-reported outcomes (PROs) are outcomes evaluated by patients based on their perception of their disease and treatment.
Objectives: Determine antipsoriatic treatment-related adherence, quality of life (QoL) and satisfaction.
Materials And Methods: We conducted an observational cross-sectional, prospective, and single-center study in which PROs surveys were conducted on adherence (Morisky-Green [MG] test), treatment satisfaction (Spanish Questionnaire of Treatment Satisfaction in Psoriasis [CESTEP]) and QoL (Skindex-29 and DLQI).
JMIR Dermatol
June 2023
Background: Atopic dermatitis (AD) is the most prevalent inflammatory skin disorder, characterized by impaired epidermal barrier function and an altered immune response, both of which are influenced by vitamin D deficiency. Single-nucleotide polymorphisms (SNPs) in VDR and CYP24A1 have been previously associated with AD.
Objective: We sought to characterize the associations between the VDR and CYP24A1 polymorphisms and the vitamin D and lipid biochemical profile in children diagnosed with AD.